PTHS·171126204·US·equity·Healthcare - Biotechnology-Activist
PTHS (PELTHOS THERAPEUTICS INC) is held by 6 institutional investors as of Q1 2026. Largest holders: CANTOR FITZGERALD, L. P. ($870,297), GEODE CAPITAL MANAGEMENT, LLC ($321,242), Steward Partners Investment Advisory, LLC ($40,129). Net institutional sentiment: Bullish.
See how PTHS's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer